A metabolic profile of polyamines in parkinson disease: A promising biomarker. Issue 2 (1st July 2019)
- Record Type:
- Journal Article
- Title:
- A metabolic profile of polyamines in parkinson disease: A promising biomarker. Issue 2 (1st July 2019)
- Main Title:
- A metabolic profile of polyamines in parkinson disease: A promising biomarker
- Authors:
- Saiki, Shinji
Sasazawa, Yukiko
Fujimaki, Motoki
Kamagata, Koji
Kaga, Naoko
Taka, Hikari
Li, Yuanzhe
Souma, Sanae
Hatano, Taku
Imamichi, Yoko
Furuya, Norihiko
Mori, Akio
Oji, Yutaka
Ueno, Shin‐Ichi
Nojiri, Shuko
Miura, Yoshiki
Ueno, Takashi
Funayama, Manabu
Aoki, Shigeki
Hattori, Nobutaka - Abstract:
- Abstract : Objective: Aging is the highest risk factor for Parkinson disease (PD). Under physiological conditions, spermidine and spermine experimentally enhance longevity via autophagy induction. Accordingly, we evaluated the ability of each polyamine metabolite to act as an age‐related, diagnostic, and severity‐associated PD biomarker. Methods: Comprehensive metabolome analysis of plasma was performed in Cohort A (controls, n = 45; PD, n = 145), followed by analysis of 7 polyamine metabolites in Cohort B (controls, n = 49; PD, n = 186; progressive supranuclear palsy, n = 19; Alzheimer disease, n = 23). Furthermore, 20 patients with PD who were successively examined within Cohort B were studied using diffusion tensor imaging (DTI). Association of each polyamine metabolite with disease severity was assessed according to Hoehn and Yahr stage (H&Y) and Unified Parkinson's Disease Rating Scale motor section (UPDRS‐III). Additionally, the autophagy induction ability of each polyamine metabolite was examined in vitro in various cell lines. Results: In Cohort A, N 8‐acetylspermidine and N ‐acetylputrescine levels were significantly and mildly elevated in PD, respectively. In Cohort B, spermine levels and spermine/spermidine ratio were significantly reduced in PD, concomitant with hyperacetylation. Furthermore, N 1, N 8‐diacetylspermidine levels had the highest diagnostic value, and correlated with H&Y, UPDRS‐III, and axonal degeneration quantified by DTI. The spermine/spermidineAbstract : Objective: Aging is the highest risk factor for Parkinson disease (PD). Under physiological conditions, spermidine and spermine experimentally enhance longevity via autophagy induction. Accordingly, we evaluated the ability of each polyamine metabolite to act as an age‐related, diagnostic, and severity‐associated PD biomarker. Methods: Comprehensive metabolome analysis of plasma was performed in Cohort A (controls, n = 45; PD, n = 145), followed by analysis of 7 polyamine metabolites in Cohort B (controls, n = 49; PD, n = 186; progressive supranuclear palsy, n = 19; Alzheimer disease, n = 23). Furthermore, 20 patients with PD who were successively examined within Cohort B were studied using diffusion tensor imaging (DTI). Association of each polyamine metabolite with disease severity was assessed according to Hoehn and Yahr stage (H&Y) and Unified Parkinson's Disease Rating Scale motor section (UPDRS‐III). Additionally, the autophagy induction ability of each polyamine metabolite was examined in vitro in various cell lines. Results: In Cohort A, N 8‐acetylspermidine and N ‐acetylputrescine levels were significantly and mildly elevated in PD, respectively. In Cohort B, spermine levels and spermine/spermidine ratio were significantly reduced in PD, concomitant with hyperacetylation. Furthermore, N 1, N 8‐diacetylspermidine levels had the highest diagnostic value, and correlated with H&Y, UPDRS‐III, and axonal degeneration quantified by DTI. The spermine/spermidine ratio in controls declined with age, but was consistently suppressed in PD. Among polyamine metabolites, spermine was the strongest autophagy inducer, especially in SH‐SY5Y cells. No significant genetic variations in 5 genes encoding enzymes associated with spermine/spermidine metabolism were detected compared with controls. Interpretation: Spermine synthesis and N 1, N 8‐diacetylspermidine may respectively be useful diagnostic and severity‐associated biomarkers for PD. ANN NEUROL 2019;86:251–263 … (more)
- Is Part Of:
- Annals of neurology. Volume 86:Issue 2(2019)
- Journal:
- Annals of neurology
- Issue:
- Volume 86:Issue 2(2019)
- Issue Display:
- Volume 86, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 86
- Issue:
- 2
- Issue Sort Value:
- 2019-0086-0002-0000
- Page Start:
- 251
- Page End:
- 263
- Publication Date:
- 2019-07-01
- Subjects:
- Neurology -- Periodicals
Pediatric neurology -- Periodicals
Nervous system -- Surgery -- Periodicals
616.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8249 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/109668537 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/76507645 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ana.25516 ↗
- Languages:
- English
- ISSNs:
- 0364-5134
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1043.140000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 16457.xml